<DOC>
	<DOCNO>NCT00992108</DOCNO>
	<brief_summary>Botulinum toxin-A ( BTX-A ) prevent release acetylcholine presynaptic terminal neuromuscular junction . It propose effective spastic condition head neck include oromandibular dystonias , bruxism , muscular hypertrophy ( 1,2,3,4 ) . However , one randomize , double-blinded , placebo control trial complete involve 20 patient demonstrate objective subjective improvement BTX-A treat group treat saline one week , one month , six month ( 5 ) . Currently , orofacial pain practice , diagnosis masticatory myofascial pain head region make , patient treat standard myofascial protocol . This protocol involve stretch , application moist heat , spray stretch , lidocaine trigger point injection masticatory muscle . This consider standard care among orofacial pain practioners . There randomize , double-blinded , head-to-head trial compare BTX-A injection lidocaine injection treatment masticatory myofacial pain . Moreover , study , muscle target use surface landmarks confirmatory test guarantee medication administer intended muscle . In previous study , medial lateral pterygoid muscle , important masticatory muscle often hyperactive masticatory myofacial pain inject due lack palpable surface landmark . Ultrasound electromyography ( EMG ) guidance help u locate muscle . The purpose study objectively measure functional improvement patient masticatory myofascial pain injected lidocaine versus BTX-A . A pilot study enrol 20 patient propose . 20 patient randomize receive either BTX-A lidocaine injection bilateral temporalis , masseter , medial lateral pterygoid . Objective subjective clinical parameter measure . These include pain rest chewing , maximum non-assisted assist mouth opening , protrusive laterotrusive jaw movement , subjective efficacy treatment , side-effects treatment . Patients assessed baseline , one week , one month , three month procedure .</brief_summary>
	<brief_title>Efficacy Botulinum Toxin Versus Lidocaine Treating Masticatory Myofascial Face Pain Using Ultrasound EMG Guided Techniques</brief_title>
	<detailed_description />
	<mesh_term>Facial Pain</mesh_term>
	<mesh_term>Lidocaine</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>Subjects identifiable painful myofascial trigger point masseter , temporalis , medial lateral pterygoid muscle . Subjects examine principle investigator determine individual suitable candidate study , base active trigger point willingness participate study Pregnant woman exclude participation potential risk note product label indication . Individuals age 65 exclude per product label indication reflect lack data individual age 65 .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Bruxism</keyword>
	<keyword>Myofascial pain</keyword>
	<keyword>EMG</keyword>
	<keyword>Ultrasound</keyword>
	<keyword>Masticatory myofascial face pain bruxism clench</keyword>
</DOC>